In a landmark study, Israeli researchers demonstrated that a human can direct a DNA‑based nanobot inside a living cockroach using only thought. The breakthrough was published in the peer‑reviewed journal PLOS ONE.

The team trained a computer algorithm to recognize the brainwave signatures produced during mental arithmetic. Subjects wore an EEG cap that transmitted neural activity to the software, which was linked to an electromagnetic coil surrounding the cockroach.

When the operator focused on arithmetic, a gate within the nanobot opened, releasing a fluorescent‑labelled drug into the insect’s bloodstream. This proof‑of‑concept shows that mind‑driven activation of nanorobots is possible.

While the experiment used a cockroach, the implications extend to human medicine. The authors envision a future where psychiatrists inject patients with programmable nanobots that respond to abnormal brainwave patterns, delivering targeted medication in real time.

For example, a wearable EEG sensor could detect a drop in attention in someone with ADHD and trigger the bots to release a micro‑dose of Ritalin. The same platform could be adapted to treat schizophrenia, depression, or autism by delivering the appropriate therapeutics only when needed.

Lead researcher Sachar Arnon explained to New Scientist that the technology “could track brain states that underlie ADHD or schizophrenia…It could be modified to suit your needs.”